Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

Acute aortic thrombosis in COVID-19

Baeza, C., González, A., Torres, P., Pizzamiglio, M., Díaz, A. B. A., & Aparicio, C. (2020) · Journal of Vascular Surgery Cases and Innovative Techniques · doi:10.1016/j.jvscit.2020.06.013 · Cited by 35

Stroke and Novel Coronavirus Infection in Humans: A Systematic Review and Meta-Analysis

Lee, K. W., Khan, A. H. K. Y., Ching, S. M., Chia, P. K., Loh, W. C., Rashid, A. M. A., Baharin, J., Mat, L. N. I., Sulaiman, W. A. W., Devaraj, N. K., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.579070 · Cited by 39

Impact of COVID-19 on Outcomes in Ischemic Stroke Patients in the United States

de Havenon, A., Ney, J. P., Callaghan, B. C., Delic, A., Hohmann, S. F., Shippey, E., Esper, G. J., Stulberg, E. L., Tirschwell, D., Frontera, J. A., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105535 · Cited by 35

The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19

Braz-de-Melo, H. A., Faria, S. S., Pasquarelli-do-Nascimento, G., Santos, I. D. O., Kobinger, G., & Magalhães, K. G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.615333 · Cited by 36

Ischaemic stroke and SARS-CoV-2 infection: a causal or incidental association?

Barrios-López, J. M., Rego-García, I., Martinez, C., Romero-Fábrega, J. C., Rodríguez, M. R., Ruiz-Giménez, J., Sevilla, F. E., Mínguez‐Castellanos, A., & Fernández-Pérez, M. D. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2020.05.008 · Cited by 35

D‐dimer Triage for COVID‐19

Li, C., Hu, B., Zhang, Z., Qin, W., Zhu, Z., Zhai, Z., Davidson, B. L., & Wang, C. (2020) · Academic Emergency Medicine · doi:10.1111/acem.14037 · Cited by 35

Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options

Huang, B., Ling, R., Cheng, Y., Wen, J., Dai, Y., Huang, W., Zhang, S., Lu, X., Luo, Y., & Jiang, Y.-Z. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.013 · Cited by 38

Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: A review

Kasinathan, G., & Sathar, J. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.06.035 · Cited by 35

Immunometabolic Status of COVID-19 Cancer Patients

Sica, A., Colombo, M. P., Trama, A., Horn, L., Garassino, M. C., & Torri, V. (2020) · Physiological Reviews · doi:10.1152/physrev.00018.2020 · Cited by 35

Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19

Rey, J. R., Caro‐Codón, J., Pinedo, I. D. P., Merino, J. L., Iniesta, Á. M., & Lopez-Sendon, J. L. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.05.013 · Cited by 35

Clotting disorder in severe acute respiratory syndrome coronavirus 2

Pujhari, S. K., Paul, S., Ahluwalia, J., & Rasgon, J. L. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2177 · Cited by 35

Lupus anticoagulant and mortality in patients hospitalized for COVID-19

Gazzaruso, C., Mariani, G., Ravetto, C., Malinverni, L., Tondelli, E., Cerrone, M., Sala, V., Bevilacqua, L., Altavilla, T., Coppola, A., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02335-w · Cited by 35

Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?

Barkas, F., Milionis, H. J., Anastasiou, G., & Liberopoulos, E. N. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110452 · Cited by 35

Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India

Gokhale, Y. A., Mehta, R., Kulkarni, U. P., Karnik, N., Gokhale, S., Sundar, U., Chavan, S. A., Kor, A., Thakur, S., Trivedi, T. H., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05912-3 · Cited by 36

Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer

Zahran, A. M., El‐Badawy, O., Ali, W. A., Mahran, Z. G., Mahran, E. E. M. O., & Rayan, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246806 · Cited by 35

Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis

Loftus, T. J., Ungaro, R. F., Dirain, M. L. S., Efron, P. A., Mazer, M. B., Remy, K. E., Hotchkiss, R. S., Zhong, L., Bacher, R. L., Starostik, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792448 · Cited by 34

COVID-19 and the antiphospholipid syndrome

Serrano, M., Espinosa, G., Serrano, A., & Cervera, R. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103206 · Cited by 36

Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics – Lung axis hypothesis

Uzzan, M., Corcos, O., Martin, J. P. D., Tréton, X., & Bouhnik, Y. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110023 · Cited by 34

Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan

Yamashita, Y., Maruyama, Y., Satokawa, H., Nishimoto, Y., Tsujino, I., Sakashita, H., Nakata, H., Okuno, Y., Ogihara, Y., Yachi, S., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0169 · Cited by 34

Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement

Sayyadi, M., Hassani, S., Shams, M., & Dorgalaleh, A. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05234-1 · Cited by 38

Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence

Ragnoli, B., Re, B. D., Galantino, A., Kette, S., Salotti, A., & Malerba, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108945 · Cited by 38

Arterial and venous strokes in the setting of COVID-19

Kananeh, M. F., Thomas, T., Sharma, K., Herpich, F., Urtecho, J. S., Athar, M. K., Jabbour, P. M., & Shah, S. O. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.07.005 · Cited by 34

Deep vein thrombosis in hospitalized patients with coronavirus disease 2019

Chang, H., Rockman, C. R., Jacobowitz, G. R., Speranza, G., Johnson, W. S., Horowitz, J. M., Garg, K., Maldonado, T. S., Sadek, M., & Barfield, M. E. (2020) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2020.09.010 · Cited by 34

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19

Alshebri, M. S., Alshouimi, R. A., Alhumidi, H. A., & Alshaya, A. I. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00589-2 · Cited by 36

Host Genetics at the Intersection of Autoimmunity and COVID-19: A Potential Key for Heterogeneous COVID-19 Severity

Karaderi, T., Bareke, H., Kunter, İ., Şeytanoğlu, A., Çağnan, I., Balcı, D., Barin, B., Hocaoğlu, M., Rahmioğlu, N., Asilmaz, E., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586111 · Cited by 34

Inflammatory stress in SARS-COV-2 associated Acute Kidney Injury

Chen, J., Wang, W., Tang, Y., Huang, X., Yu, X., & Lan, H.-Y. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.58791 · Cited by 37

Rationales and uncertainties for aspirin use in COVID-19: a narrative review

Ahmed, H. A. S., Merrell, E., Ismail, M., Joudeh, A. I., Riley, J. B., Shawkat, A., Habeb, H., Darling, E., Goweda, R. A., Shehata, M. H., et al. (2021) · Family Medicine and Community Health · doi:10.1136/fmch-2020-000741 · Cited by 33

Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19

Gomes, C., Zuniga, M., Crotty, K. A., Qian, K., Tovar, N. C., Lin, L. H., Argyropoulos, K. V., Clancy, R. M., Izmirly, P., Buyon, J. P., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202101180 · Cited by 33

Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients

Rausch, L., Lutz, K., Schifferer, M., Winheim, E., Gruber, R., Oesterhaus, E. F., Rinke, L., Hellmuth, J. C., Scherer, C., Muenchhoff, M., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12173 · Cited by 31

EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection

Lee, Y., Riskedal, E., Kalleberg, K. T., Istre, M. S., Lind, A., Lund‐Johansen, F., Reiakvam, O. M., Søraas, A. V. L., Harris, J. R., Dahl, J. A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-15467-1 · Cited by 33

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery

Couto, P. S., Al-Arawe, N., Filgueiras, I. S., Fonseca, D. L. M., Hinterseher, I., Catar, R. A., Chinnadurai, R., Bersenev, A., Cabral-Marques, O., Moll, G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1200180 · Cited by 35

Catastrophic acute bilateral lower limbs necrosis associated with COVID‐19 as a likely consequence of both vasculitis and coagulopathy

Giudice, P. D., Boudoumi, D., Guen, B. L., Reverte, M., Gutnecht, J., Lacour, J. ‐., Kraemer, J.-P., Motard, A., & Roa, M. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16763 · Cited by 33

A comprehensive review of imaging findings in COVID-19 - status in early 2021

Afshar‐Oromieh, A., Prosch, H., Schaefer‐Prokop, C. M., Bohn, K. P., Alberts, I., Mingels, C., Thurnher, M. M., Cumming, P. D., Shi, K., Peters, A. A., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05375-3 · Cited by 35

Atención al ictus agudo durante la pandemia por COVID-19. Recomendaciones Plan Ictus Madrid

Rodríguez‐Pardo, J., Fuentes, B., de Leciñana, M. A., Campollo, J., Calleja, P., Ruiz, J. C., Herrero, J. E., Leal, R. G., Núñez, A. G., Cerezo, J. F. G., et al. (2020) · Neurología · doi:10.1016/j.nrl.2020.04.008 · Cited by 33

Lung Pathology of COVID-19 in Moscow

Samsonova, M. V., Mikhalyova, L. M., Zairatyants, O. V., Varyasin, V. V., Bykanova, A. V., Od, M., Berezovsky, Y. S., Tishkevitch, O. A., Gomzikova, E. A., Chernyayev, A. L., et al. (2020) · Russian Journal of Archive of Pathology · doi:10.17116/patol20208204132 · Cited by 33

Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: A single center retrospective, observational study from the Abu Dhabi, United Arab Emirates

John, S., Hussain, S. I., Piechowski‐Jóźwiak, B., Dibu, J. R., Kesav, P., Bayrlee, A., Elkambergy, H., John, T. L. S., Röser, F., & Mifsud, V. A. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106227 · Cited by 32

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

Amigues, I., Pearlman, A. H., Patel, A. M., Reid, P. D., Robinson, P. C., Sinha, R. R., Kim, A. H. J., Youngstein, T., Jayatilleke, A., & Konig, M. F. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1847084 · Cited by 33

Incidence, Characteristics, Laboratory Findings and Outcomes in Acro-Ischemia in COVID-19 Patients

Alonso, M. N., Forte, T. M., García-León, N., Vullo, P. A., Ramírez‐Olivencia, G., Estébanez, M., & Álvarez-Marcos, F. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s276530 · Cited by 33

A Potent SARS-CoV-2 Neutralizing Human Monoclonal Antibody That Reduces Viral Burden and Disease Severity in Syrian Hamsters

Fagre, A. C., Manhard, J., Adams, R., Eckley, M., Zhan, S., Lewis, J., Rocha, S. M., Woods, C., Kuo, K., Liao, W., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614256 · Cited by 33

Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs

Doğan, Ö. A., Köse, B., Ağaoğlu, N. B., Yıldız, J., Alkurt, G., Demirkol, Y. K., İrvem, A., Doğanay, G. D., & Doğanay, H. L. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.114049 · Cited by 34

COVID-19–associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron

Bouquegneau, A., Erpicum, P., Grosch, S., Habran, L., Hougrand, O., Huart, J., Krzesinski, J.-M., Misset, B., Hayette, M., Delvenne, P., et al. (2021) · Kidney360 · doi:10.34067/kid.0006992020 · Cited by 37

Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model

Maeda, D. L. N. F., Tian, D., Yu, H., Dar, N., Rajasekaran, V., Meng, S., Mahsoub, H. M., Sooryanarain, H., Wang, B., Heffron, C. L., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025622118 · Cited by 33

“Post Coronavirus Disease (COVID-19) Reactivation of a Quiescent Unilateral Anterior Uveitis”

Sanjay, S., Mutalik, D., Gowda, S., Mahendradas, P., Kawali, A., & Shetty, R. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00985-2 · Cited by 33

Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19

Tizenberg, B., Brenner, L. A., Lowry, C. A., Okusaga, O. O., Benavides, D. R., Hoisington, A. J., Benros, M. E., Stiller, J. W., Kessler, R. C., & Postolache, T. T. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-021-01275-3 · Cited by 33

Role of LL-37 in thrombotic complications in patients with COVID-19

Duan, Z., Zhang, J., Chen, X., Liu, M., Zhao, H., Jin, L., Zhang, Z., Luan, N., Meng, P., Wang, J., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04309-y · Cited by 33

SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo

Nakayama, E. E., & Shioda, T. (2023) · Microorganisms · doi:10.3390/microorganisms11041015 · Cited by 32

Neurological Involvement of Coronavirus Disease 2019: A Systematic ReviewPreprint

Ghannam, M., Alshaer, Q. N., Al-Chalabi, M., Zakarna, L., Robertson, J., & Manousakis, G. (2020) · doi:10.21203/rs.3.rs-31183/v1 · Cited by 35

COVID-19: quarantine, isolation, and lifestyle diseases

Rehman, H., & Ahmad, M. I. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1833346 · Cited by 35

Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient

Hinterseer, M., Zens, M., Wimmer, R., Delladio, S., Lederle, S., Kupatt, C., & Hartmann, B. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01663-4 · Cited by 32

Neurological complications of COVID-19: a preliminary review

Pryce-Roberts, A., Talaei, M., & Robertson, N. P. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09941-x · Cited by 32

Venous thromboembolism in the era of COVID-19

Kyriakoulis, K. G., Kokkinidis, D. G., Kyprianou, I. A., Papanastasiou, C. A., Barakakis, P. A., Doundoulakis, I., Bakoyiannis, C., Giannakoulas, G. A., & Palaiodimos, L. (2020) · Phlebology The Journal of Venous Disease · doi:10.1177/0268355520955083 · Cited by 32

Complications and Pathophysiology of COVID-19 in the Nervous System

Yu, H., Sun, T., & Feng, J. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.573421 · Cited by 33

Potential mechanisms of cerebrovascular diseases in COVID-19 patients

Lou, M., Yuan, D., Liao, S., Tong, L., & Li, J. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00948-2 · Cited by 33

The diagnostic dilemma of bilateral optic neuritis and idiopathic intracranial hypertension coexistence in a patient with recent COVID‐19 infection

Sardar, S., Safan, A. S., Okar, L., Sadik, N. D., & Adeli, G. (2021) · Clinical Case Reports · doi:10.1002/ccr3.4347 · Cited by 31

Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19

Jesuthasan, A., Massey, F., Manji, H., Zandi, M. S., & Wiethoff, S. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117608 · Cited by 34

Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review

Ullah, I., Sohail, A., Shah, M. U. F. A., Khurshid, M., Diwan, M. N., Qadir, A., & Irfan, M. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102898 · Cited by 32

Characteristics of a COVID-19 Cohort With Large Vessel Occlusion: A Multicenter International Study

Jabbour, P. M., Dmytriw, A. A., Sweid, A., Piotin, M., Bekelis, K., Sourour, N. A., Raz, E., Linfante, I., Dabus, G., Kole, M., et al. (2022) · Neurosurgery · doi:10.1227/neu.0000000000001902 · Cited by 32

Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19

Mir, M. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03715-y · Cited by 38

Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19

Carneiro, T. S., Dashkoff, J., Leung, L. Y., Nobleza, C. O. S., Marulanda-Londoño, E. T., Hathidara, M. Y., Koch, S., Sur, N. B., Boske, A., Voetsch, B., et al. (2020) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2020.105201 · Cited by 31

Microvascular Angiopathic Consequences of COVID-19

Nalugo, M., Schulte, L., Masood, M. F., & Zayed, M. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.636843 · Cited by 31

Manifestaciones clínicas de la COVID-19

Benítez, T. P., Rojas, A. L., Báez, L. M., Orozco, A. C. M., Avendaño, A. R. D., Corona-Villalobos, C. A., Guzmán-Valderrábano, C., Rangel, L. G. G., Lechuga-Trejo, I., Ramírez, B. A. A., et al. (2020) · Revista Latinoamericana de Infectología Pediátrica · doi:10.35366/96668 · Cited by 34

Consensus statement – suggested recommendations for acute stroke management during the COVID-19 pandemic: Expert group on behalf of the indian stroke association

Bhatia, R., Sylaja, P. N., Srivastava, M. V. P., Khurana, D., Pandian, J. D., Suri, V., Pradeep, V. G., Kumaravelu, S., Huded, V., Surya, N., et al. (2020) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_302_20 · Cited by 31

Decline in acute upper gastrointestinal bleeding during COVID-19 pandemic after initiation of lockdown in Austria

Schmiderer, A., Schwaighofer, H., Niederreiter, L., Profanter, C., Steinle, H., Ziachehabi, A., & Tilg, H. (2020) · Endoscopy · doi:10.1055/a-1178-4656 · Cited by 32

A Collaborative Multidisciplinary Approach to the Management of Coronavirus Disease 2019 in the Hospital Setting

Razonable, R. R., Pennington, K. M., Meehan, A. M., Wilson, J. W., Froemming, A. T., Bennett, C. E., Marshall, A. L., Virk, A., & Carmona, E. M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.010 · Cited by 32

Hemorrhagic encephalopathy associated with COVID-19

Krett, J. D., Jewett, G., Elton-Lacasse, C., Fonseca, K., Hahn, C. M., Au, S. S., & Koch, M. W. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577326 · Cited by 30

COVID-19 and stroke: Experience in a Ghanaian healthcare system

Sarfo, F. S., Mensah, N. O., Agyapong, F. O., Mensah, N. A., Ampofo, M., & Ovbiagele, B. I. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117044 · Cited by 31

Syncope and presyncope in patients with COVID‐19

Oates, C. P., Turagam, M. K., Musikantow, D. R., Chu, E. W., Shivamurthy, P., Lampert, J., Kawamura, I., Bokhari, M., Whang, W., Miller, M. A., et al. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14047 · Cited by 31

The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome

Cabrera-Marante, Ó., de Frías, E. R., Serrano, M., Lozano, F., Naranjo, L., Gil‐Etayo, F. J., Paz‐Artal, E., Pleguezuelo, D. E., & Serrano, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238972 · Cited by 32

Cell‐mediated immunity to SARS‐CoV‐2

Wang, X., & Gui, J. (2020) · Pediatric Investigation · doi:10.1002/ped4.12228 · Cited by 32

MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19

Bumiller‐Bini, V., Oliveira, C. F., Carvalho, T. M., Kretzschmar, G. C., Gonçalves, L. B., Alencar, N. M., Filho, M. A. G., Beltrame, M. H., & Boldt, A. B. W. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0199 · Cited by 30

Acute kidney injury in COVID-19: multicentre prospective analysis of registry data

Wan, Y. I., Bien, Z., Apea, V., Orkin, C. M., Dhairyawan, R., Kirwan, C. J., Pearse, R. M., Puthucheary, Z., & Prowle, J. R. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab071 · Cited by 31

Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries

Rejeki, M. S., Sarnadi, N., Wihastuti, R., Fazharyasti, V., Samin, W. Y., Yudhaputri, F. A., Johar, E., Nurainy, N., Bachtiar, N. S., & Muljono, D. H. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100931 · Cited by 31

The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases

Acanfora, D., Acanfora, C., Ciccone, M. M., Scicchitano, P., Bortone, A. S., Uguccioni, M., & Casucci, G. (2021) · Viruses · doi:10.3390/v13101904 · Cited by 30

Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review

Fernández‐Lázaro, D., & Garrosa, M. (2021) · Viruses · doi:10.3390/v13101916 · Cited by 34

Virchow’s Triad and the Role of Thrombosis in COVID-Related Stroke

González-González, F. J., Ziccardi, M. R., & McCauley, M. D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.769254 · Cited by 31

Ischemic stroke in COVID‐19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis

Strambo, D., Marchis, G. M. D., Bonati, L. H., Arnold, M., Carrera, E., Galletta, S., Nedeltchev, K., Kahles, T., Cereda, C. W., Bianco, G., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15199 · Cited by 31

Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury

Wang, L., Yang, J., & Xu, J. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.11.022 · Cited by 34

Arterial thrombotic complications in hospitalized patients with COVID-19

Rey, J. R., Caro‐Codón, J., Pinedo, I. D. P., Merino, J. L., Iniesta, Á. M., & López-Sendón, J. L. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.05.008 · Cited by 30

SARS-CoV-2 infection and its association with thrombosis and ischemic stroke: a review

Snell, J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.072 · Cited by 34

CUADRO CLÍNICO DEL COVID-19

Gil, R., Bitar, P., Cristian Deza, E., Dreyse, J., FLORENZANO, M., V, Ibarra, C., Jorge Jorquera, A., Melo, J., Olivi, H., Parada, M. T., et al. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.11.004 · Cited by 38

Prophylaxis and treatment of COVID-19 related venous thromboembolism

Kaptein, F. H. J., Stals, M. A. M., Huisman, M. V., & Klok, F. A. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.1891788 · Cited by 31

Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019

Serrano, M., Espinosa, G., Lalueza, A., Bravo‐Gallego, L. Y., Díaz‐Simón, R., Garcinuño, S., Gil‐Etayo, F. J., Moisés, J., Naranjo, L., Prieto‐González, S., et al. (2021) · ACR Open Rheumatology · doi:10.1002/acr2.11245 · Cited by 30

Heart failure outcomes and Covid-19

Standl, E., & Schnell, O. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108794 · Cited by 31

Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID ‐19 patients

Sadeghzadeh‐Bazargan, A., Rezai, M., Nobari, N. N., Mozafarpoor, S., & Goodarzi, A. (2021) · Journal of Cutaneous Pathology · doi:10.1111/cup.14059 · Cited by 30

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove

Sciascia, S., Radin, M., Bazzan, M., Montaruli, B., Cosseddu, D., Norbiato, C., Bertero, M. T., CARIGNOLA, R., Bacco, B., Cassarino, S. G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687534 · Cited by 30

Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort

Liu, T., Dai, J., Yang, Z., Yu, X., Xu, Y., Shi, X., Wei, D., Tang, Z., Xu, G., Xu, W., et al. (2021) · 中国科学通报：英文版 · doi:10.1016/j.scib.2021.07.033 · Cited by 30

p38 activation and viral infection

Wang, L., Xia, Z., Tang, W., Sun, Y. N., Wu, Y., Kwok, H. F., Sun, F., & Cao, Z. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2021.29 · Cited by 30

Koagulopati pada Coronavirus Disease-2019 (COVID-19): Tinjauan pustaka

Willim, H. A., Hardigaloeh, A. T., Supit, A. I., & Handriyani, H. (2020) · Intisari Sains Medis · doi:10.15562/ism.v11i3.766 · Cited by 30

Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review

Riou, M., Coste, F., Meyer, A., Enache, I., Talha, S., Charloux, A., Reboul, C., & Gény, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094941 · Cited by 32

NETosis: A key player in autoimmunity, COVID-19, and long COVID

Monsalve, D. M., Acosta‐Ampudia, Y., Acosta, N. G., Celis-Andrade, M., Şahin, A., Morva, A., Shoenfeld, Y., & Ramı́rez-Santana, C. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100280 · Cited by 32

Cerebrovascular disease in COVID-19: Is there a higher risk of stroke?

Altable, M., & de la Serna, J. M. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100092 · Cited by 29

COVID-19 and acute ischemic stroke – A case series from Dubai, UAE

Khan, M., Ibrahim, R. H., Siddiqi, S. A., Kerolos, Y. S. S., Al‐Kaylani, M., Alrukn, S., & Krieger, D. W. (2020) · International Journal of Stroke · doi:10.1177/1747493020938285 · Cited by 29

Ictus isquémico e infección por SARS-CoV-2, ¿asociación casual o causal?

Barrios-López, J. M., Rego-García, I., Martinez, C., Romero-Fábrega, J. C., Rodríguez, M. R., Ruiz-Giménez, J., Sevilla, F. E., Mínguez‐Castellanos, A., & Fernández-Pérez, M. D. (2020) · Neurología · doi:10.1016/j.nrl.2020.05.002 · Cited by 31

Platelets and renal failure in the SARS-CoV-2 syndrome

Taha, M., Sano, D., Hanoudi, S. N., Esber, Z., Elahi, M., Gabali, A., Chopra, T., Drăghici, S., & Samavati, L. (2020) · Platelets · doi:10.1080/09537104.2020.1817361 · Cited by 29

Case Report: COVID-19 Associated Renal Infarction and Ascending Aortic Thrombosis

Mukherjee, A., Ghosh, R., & Furment, M. M. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0869 · Cited by 31

The neurological sequelae of pandemics and epidemics

Valério, F., Whitehouse, D. P., Menon, D. K., & Newcombe, V. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10261-3 · Cited by 30

Manifestaciones cutáneas en pacientes con COVID-19: características clínicas y mecanismos fisiopatológicos postulados

González, F., Correa, C. I. C., & Peñaranda, E. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2020.11.013 · Cited by 30

Fatal pulmonary arterial thrombosis in a COVID-19 patient, with asymptomatic history, occurred after swab negativization

Nonno, F. D., Colombo, D., Nardacci, R., & Falasca, L. (2021) · Thrombosis Journal · doi:10.1186/s12959-020-00255-6 · Cited by 29

The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19

Shen, L., Qiu, L., Liu, D., Wang, L., Huang, H., Ge, H., Xiao, Y., Liu, Y., Jin, J., Liu, X., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07133-3 · Cited by 29

COVID-19: a new emerging respiratory disease from the neurological perspective

El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12969-9 · Cited by 30

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2